Old Drug Holds New Promise
Added Aug 16, 2012 | Rate View top rated
New findings in University of Texas, Austin's neurobiology labs suggest that rapamycin - an FDA-approved immunosuppressant used to control organ rejection in transplant patients - may be an effective therapy for Alzheimer's, epilepsy, and even autism. A UT team led by Professor Kim Raab-Graham of the College of Natural Sciences' Center for Learning and Memory is searching for an equivalent drug that can deliver the benefit without the side effects.
Be the first to comment. Please sign in to add your thoughts below.
Watch more